4//SEC Filing
LESCHLY JAN 4
Accession 0001209191-09-034216
CIK 0001103021other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:17 PM ET
Size
85.7 KB
Accession
0001209191-09-034216
Insider Transaction Report
Form 4
CDC Operations LLC
10% Owner
Transactions
- Sale
Common Stock
2009-06-29$6.88/sh−215,791$1,484,232→ 331,714 total(indirect: See Footnote) - Sale
Common Stock
2009-06-26$6.85/sh−477,509$3,273,181→ 547,505 total(indirect: See Footnote)
Ramsay David Russ
10% Owner
Transactions
- Sale
Common Stock
2009-06-26$6.85/sh−477,509$3,273,181→ 547,505 total(indirect: See Footnote) - Sale
Common Stock
2009-06-29$6.88/sh−215,791$1,484,232→ 331,714 total(indirect: See Footnote)
CDC IV LLC
10% Owner
Transactions
- Sale
Common Stock
2009-06-26$6.85/sh−477,509$3,273,181→ 547,505 total(indirect: See Footnote) - Sale
Common Stock
2009-06-29$6.88/sh−215,791$1,484,232→ 331,714 total(indirect: See Footnote)
LESCHLY JAN
10% Owner
Transactions
- Sale
Common Stock
2009-06-26$6.85/sh−477,509$3,273,181→ 547,505 total(indirect: See Footnote) - Sale
Common Stock
2009-06-29$6.88/sh−215,791$1,484,232→ 331,714 total(indirect: See Footnote)
KARABELAS ARGERIS N
10% Owner
Transactions
- Sale
Common Stock
2009-06-26$6.85/sh−477,509$3,273,181→ 547,505 total(indirect: See Footnote) - Sale
Common Stock
2009-06-29$6.88/sh−215,791$1,484,232→ 331,714 total(indirect: See Footnote)
Footnotes (3)
- [F1]On June 26, 2009, CDC IV, LLC sold an aggregate of 477,509 shares of Common Stock of BioDelivery Sciences International, Inc. at an average gross price per share of $6.8547. The individual trades made by CDC IV, LLC on June 26, 2009 are set forth on Exhibit 1(a) attached hereto.
- [F2]The reportable securities are owned directly by CDC IV, LLC and indirectly by CDC Operations LLC, David R. Ramsay, Argeris Karabelas and Jan Leschly. CDC Operations LLC disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that CDC Operations LLC is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of its pecuniary interest therein. David R. Ramsay, Argeris Karabelas and Jan Leschly are each partners of CDC Operations LLC. Messrs. Ramsay, Karabelas and Leschly each disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that Messrs. Ramsay, Karabelas and Leschly is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein.
- [F3]On June 29, 2009, CDC IV, LLC sold an aggregate of 215,791 shares of Common Stock of BioDelivery Sciences International, Inc. at an average gross price per share of $6.8781. The individual trades made by CDC IV, LLC on June 29, 2009 are set forth on Exhibit 1(b) attached hereto.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001204568
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:17 PM ET
- Size
- 85.7 KB